Prioritizing in the New Normal

Register free: http://www.appliedclinicaltrialsonline.com/act_w/normal

Event Overview:

Throughout the global COVID-19 pandemic, clinical research activity has morphed and changed through the shut down and eventual reopening of research sites and studies. During this webcast, we will discuss how to prioritize in this “new normal”, whether that involves reopening sites, catching up on a backlog of work, or fully implementing remote capabilities. In addition, we plan to discuss some of the important aspects of clinical trial management from a Sponsor/CRO level and what mindset shifts may need to occur to proactively create study plans. A few areas of focus will include:

• Resuming activity for ongoing studies, including strategies for increasing enrollment and adjusting study plans to account for new processes
• Planning upcoming studies, including assessing potential sites, using electronic informed consent, determining when to use remote monitoring, and creating an electronic Trial Master File
• Adjusting budgets for sites and CRO teams

Key Learning Objectives:

• Understanding what short-term solutions should be considered as long-term process changes for clinical trials
• Ability to critically think through current projects and apply changes to continue clinical study progress
• Determining how to plan for future studies when considering the long-term changes to industry processes
  

Speakers: Brandy Chittester, MS, CCRA, President, IMARC Research, Inc.

Stephani D. Hulec, MS, CCRA, Associate Director, Monitoring Services, IMARC Research, Inc.

Time and date: Wednesday, Sept. 16, 2020 at 2pm EDT | 1pm CDT | 11am PDT

On demand available after airing until Sept. 16, 2021.

Sponsor: Imarc Research

Register free: http://www.appliedclinicaltrialsonline.com/act_w/normal